Stock Detail
CAMBREX CORPORATION
Sector: Biotechnology
Latest Quote @ Tue May 5 08:39:26 (15 min delayed)
| $11.70 |
$13.45 |
$13.02 |
-0.14 |
-1.06% |
|
Last Day's Data
| $13.02 |
$13.25 |
$0.00 |
0.00% |
0.00 |
$13.16 |
| $13.16 |
$12.88 |
93,364.00 |
390.97M |
146,956.00 |
5.94 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 13.42 |
13.22 |
13.05 |
12.85 |
12.68 |
Stock Profile
Cambrex Corporation and its subsidiaries provide products and services to accelerate drug discovery, development, and manufacturing processes for human therapeutics worldwide. It operates through three segments: Bioproducts, Biopharma, and Human Health. The Bioproducts segment offers research products and therapeutic application products; The Biopharma segment provides contract biopharmaceutical process development and manufacturing services; and The Human Health segment produces active pharmaceutical ingredients and pharmaceutical intermediates for use in the production of prescription and over-the-counter drug products, as well as other custom chemicals derived from organic chemistry. Cambrex Corporation sells its products through its direct sales force, independent distributors, and its e-commerce Web site to pharmaceutical and biopharmaceutical companies, generic drug companies, biotechnology companies, and research organizations. The company was founded in 1981 and is based in East Rutherford, New Jersey.
